CRT 2024

CARDIOTUBE INTERVIEW - LATE BREAKING CLINICAL SCIENCE: Safety and Efficacy of the Xience Everolimus-Eluting Stent for Treatment of In-Stent Restenosis – An ILUMIEN IV Substudy

Interviewer(s)

• 

  Aloke V. Finn, MD

  Medical Director CVPath/Assoc. Prof. Of Medicine University of Maryland
  CVPath
  Gaithersburg, Maryland, United States

  No relationships to disclose

Interviewee(s)

• 

  Ziad Ali, MD, DPhil

  Director
  DeMatteis Cardiovascular Institute
  Columbia University
  Roslyn, New York, United States

  Disclosure information not submitted.